The Elastin Receptor Complex: An Emerging Therapeutic Target Against Age-Related Vascular Diseases - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue Frontiers in Endocrinology Année : 2022

The Elastin Receptor Complex: An Emerging Therapeutic Target Against Age-Related Vascular Diseases

Dignê Tembely
  • Fonction : Auteur
Aubéri Henry
  • Fonction : Auteur
Laetitia Vanalderwiert
  • Fonction : Auteur
Kevin Toussaint
  • Fonction : Auteur
Amar Bennasroune
  • Fonction : Auteur
Sébastien Blaise
Hervé Sartelet
  • Fonction : Auteur
Stéphane Jaisson
  • Fonction : Auteur
Céline Galés
  • Fonction : Auteur
Laurent Martiny
  • Fonction : Auteur
Laurent Duca
  • Fonction : Auteur
Béatrice Romier-Crouzet
  • Fonction : Auteur

Résumé

The incidence of cardiovascular diseases is increasing worldwide with the growing aging of the population. Biological aging has major influence on the vascular tree and is associated with critical changes in the morphology and function of the arterial wall together with an extensive remodeling of the vascular extracellular matrix. Elastic fibers fragmentation and release of elastin degradation products, also known as elastin-derived peptides (EDPs), are typical hallmarks of aged conduit arteries. Along with the direct consequences of elastin fragmentation on the mechanical properties of arteries, the release of EDPs has been shown to modulate the development and/or progression of diverse vascular and metabolic diseases including atherosclerosis, thrombosis, type 2 diabetes and nonalcoholic steatohepatitis. Most of the biological effects mediated by these bioactive peptides are due to a peculiar membrane receptor called elastin receptor complex (ERC). This heterotrimeric receptor contains a peripheral protein called elastin-binding protein, the protective protein/cathepsin A, and a transmembrane sialidase, the neuraminidase-1 (NEU1). In this review, after an introductive part on the consequences of aging on the vasculature and the release of EDPs, we describe the composition of the ERC, the signaling pathways triggered by this receptor, and the current pharmacological strategies targeting ERC activation. Finally, we present and discuss new regulatory functions that have emerged over the last few years for the ERC through desialylation of membrane glycoproteins by NEU1, and its potential implication in receptor transactivation.
Fichier principal
Vignette du fichier
2022-01.pdf (706.96 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03796116 , version 1 (04-10-2022)

Identifiants

Citer

Dignê Tembely, Aubéri Henry, Laetitia Vanalderwiert, Kevin Toussaint, Amar Bennasroune, et al.. The Elastin Receptor Complex: An Emerging Therapeutic Target Against Age-Related Vascular Diseases. Frontiers in Endocrinology, 2022, 13, ⟨10.3389/fendo.2022.815356⟩. ⟨hal-03796116⟩

Collections

CNRS URCA MEDYC
11 Consultations
21 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More